Induction of Clinical Response Using Rifaximin in Crohn's Disease
This study is currently recruiting participants.
Verified June 2012 by University of Washington
Sponsor:
Scott Lee
Collaborator:
Salix Pharmaceuticals
Information provided by (Responsible Party):
Scott Lee, University of Washington
ClinicalTrials.gov Identifier:
NCT00603616
First received: January 16, 2008
Last updated: June 13, 2012
Last verified: June 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2012 |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |